Who We Are
The WeCan Study is an effort of Multidisciplinary Association for Psychedelic Studies (MAPS). This research is being conducted by Principal Investigator Dr. Sue Sisley at the Scottsdale Research Institute (SRI). Our mission is to collect objective information about the efficacy of cannabis-based treatments for PTSD and other disorders.
In Cooperation With
The Food and Drug Administration
Drug Enforcement Administration
National Institute on Drug Abuse
Colorado Dept. of Health & Environment
Multidisciplinary Association for Psychedelic Studies
National American Legion
Scottsdale Research Institute
How We’ll Protect Your Privacy
All information that you give will be kept strictly confidential. The information collected about you will not directly identify you (for example, by name, address, or social security number). Instead, a code number will be used for your information. This is a federally authorized study. Your participation WILL NOT affect your VA benefits.
About the Study
The WeCan Study is a Phase 2 pilot study looking at the safety and efficacy of smoked cannabis in treating the symptoms of PTSD in veterans. Dr. Sue Sisley is the principal Investigator at Scottsdale Research Institute and is working with the study Sponsor, MAPS, whose mission is to collect objective information about the efficacy of cannabis-based treatments for PTSD and other disorders. A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required by U.S. Law.
How the Study works
The WeCan Study is a multi-staged study designed to test if one of four different concentrations of cannabis are safe and helpful for people with PTSD. Participation in the study can last from 10 to 18 weeks, and involves making regular visits to Scottsdale Research Institute’s clinic in North Phoenix, smoking cannabis provided by the clinic, and providing information about PTSD symptoms.
Fill out the brief form on the Get Started page or at the bottom of any page to contact us.
Within a few days we will contact you with more information and the option to schedule a prescreening interview.
Attend your prescreening interview and decide if you would like to volunteer.
What We’ll Accomplish
Results from the WeCan Study will help to advance the standard of care for PTSD in veterans, potentially providing avenues for new research and treatment, as well as providing clear, scientifically sound data on the efficacy of cannabis for PTSD.
Against the backdrop of the nation’s largest Veterans Day parade, Democratic Gov. Andrew Cuomo announced this month he’d sign legislation making New York the latest in a fast-rising tide of states to OK therapeutic pot as a PTSD treatment, though it’s illegal…
The Cannabist reports on a letter sent by members of the House Committee on Veterans Affairs to the Veterans Administration Secretary David Shulkin, urging the VA to allow research into the efficacy of marijuana for treating symptoms…
Government Executive interviews military veterans who advocate for the use of medical marijuana for treating their symptoms of PTSD. Government Executive highlights MAPS’ ongoing study researching the effects of smoked marijuana as a treatment for…
Become a Volunteer
To see if you qualify, fill in the below form and we will be in touch with you within few days.